Corrigendum to “Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: Development of a [3.3.0]-based series and other piperidine bioisosteres” [Bioorg. Med. Chem. Lett. 24 (2014) 1062–1066]

Douglas J. Sheffler, Michael T. Nedelcovych, Richard Williams, Stephen C. Turner, Brittany B. Duerk, Megan R. Robbins, Sataya B. Jadhav, Colleen M. Niswender, Carrie K. Jones, P. Jeffrey Conn, R. Nathan Daniels*, Craig W. Lindsley

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Abstract


Original languageEnglish
Pages (from-to)2079
Number of pages1
JournalBioorganic and Medicinal Chemistry Letters
Volume27
Issue number9
DOIs
Publication statusPublished - 24 Mar 2017

Bibliographical note

Publisher Copyright:
© 2017

Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Corrigendum to “Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: Development of a [3.3.0]-based series and other piperidine bioisosteres” [Bioorg. Med. Chem. Lett. 24 (2014) 1062–1066]'. Together they form a unique fingerprint.

Cite this